About Esperanza Therapeutics, Inc.
We are pioneering the future of therapeutics research and development.
Based in Texas, our early-stage company specializes in the discovery and development of small molecule therapeutics. Our journey began through years of acemdeic resaerch and has been fostered through the Advanced Cancer Therapeutics (CPRIT-ACT) program and the Gulf Coast Consortia, where we forged vital collaborations and received comprehensive training in translating science from bench to bedside. Our innovative approaches and core porfolio of small molecules has been recognized with pilot funding from the NIH GCC-REACH program to further promote translation.
Our mission is to accelerate the discovery of transformative therapies that bring hope and healing to patients worldwide. With expertise spanning AI-driven drug design, medicinal chemistry, high-throughput screening, and a seasoned team in translational research and commercialization, we deliver innovative solutions for unmet clinical needs.
Explore our site to learn how Esperanza Therapeutics is redefining the boundaries of possibility in drug development. Together, let's create a healthier tomorrow.
